X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 14/Sep 10:02

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

Articles similaires

NIH funds new research to combat emerging viruses

news.medical.net - 14/Sep 10:02

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...

New research network focuses on high-priority viruses

news.medical.net - 14/Sep 09:43

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...

New research network focuses on high-priority viruses

news.medical.net - 14/Sep 09:43

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...

NIH awards multi-million grant for groundbreaking organ transplantation research

news.medical.net - 07/Sep 03:57

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH)...

NIH awards multi-million grant for groundbreaking organ transplantation research

news.medical.net - 07/Sep 03:57

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH)...

New $3.26 million grant launches Undiagnosed Diseases Network site in New York

news.medical.net - 17/Sep 16:55

A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of...

Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variants

news.medical.net - 06/Sep 16:33

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a...

Sorry! Image not available at this time

Creative Biolabs: Flagship Antibody Products for Neuroscience Research

mountaintoday.in - 13/Sep 19:30

Creative Biolabs offers a wide-ranging portfolio of antibody products designed to study key molecules associated with neurological diseases. New York,...

Sorry! Image not available at this time

Creative Biolabs: Flagship Antibody Products for Neuroscience Research

mountaintoday.in - 13/Sep 19:30

Creative Biolabs offers a wide-ranging portfolio of antibody products designed to study key molecules associated with neurological diseases. New York,...

Sorry! Image not available at this time

Antibodies can both help and block COVID-19 virus, finds study

knowridge.com - 13/Sep 23:41

Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising finding about how antibodies...

Les derniers communiqués

  • Aucun élément